Find clinical trials for Adenocarcinoma in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near San Diego, CA, USA:

A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

La Jolla, California, United States and 66 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Colorectal Adenocarcinoma
Pancreatic Adenocarcinoma
Drug: 5-fluorouracil
Drug: Irinotecan

Phase 1


San Diego, California, United States and 18 other locations

This research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sen...

Metastasis Prostate Adenocarcinoma
Prostate Adenocarcinoma
Drug: Docetaxel
Drug: Nivolumab

Phase 2

Xiao X. Wei, MD

La Jolla, California, United States and 5 other locations

will help in treating patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma...

Active, not recruiting
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Drug: Mesna
Drug: Fludarabine

Phase 1, Phase 2


La Jolla, California, United States and 2 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...

Lung Adenocarcinoma
Ovarian Cancer
Drug: AZD5305
Drug: AZD5335

Phase 1, Phase 2


La Jolla, California, United States and 38 other locations

designed to examine the effects of AZD0171 and durvalumab in combination with standard-of-care chemotherapy in patients with pancreatic ductal adenocarcinoma...

Active, not recruiting
Locally Advanced or Metastatic Solid Tumours
Drug: Durvalumab
Drug: AZD0171

Phase 2


La Jolla, California, United States and 35 other locations

The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...

Active, not recruiting
Adenocarcinoma of the Prostate
Biological: sipuleucel-T

Phase 3


La Jolla, California, United States and 55 other locations

A first-in-human open-label, Phase I/II study to evaluate the safety, tolerability, MTD/RP2D, PK, and preliminary efficacy of OBI-3424 administered a...

Pancreatic Adenocarcinoma
Solid Tumor
Drug: OBI-3424

Phase 1, Phase 2

OBI Pharma

La Jolla, California, United States and 4 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prost...

Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2


La Jolla, California, United States and 22 other locations

This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number...

Active, not recruiting
Lung Adenocarcinoma Stage IIIB/IV
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
Drug: Tepotinib

Phase 2

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Encinitas, California, United States and 176 other locations

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems